source
- Bayer's Sunharbo becomes first FDA-approved factor XIa inhibitor blood thinnerBayer's oral anticoagulant Sunharbo, known as asundexian, has received FDA approval, making it the first factor XIa inhibitor cleared for use in the United States. The drug is intended to lower th…
- BIO chief warns US biotech must act now to stay ahead of China’s new five-year planJohn F. Crowley, CEO of the Biotechnology Innovation Organization, says China has unveiled a five-year strategy that labels biotechnology a national pillar industry and aims to overtake the United…